#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    SAPHO syndrome Keratosis follicular Osteosarcoma metastatic Extranodal marginal zone B-cell lymphoma (MALT type) Liver abscess Acute graft versus host disease in skin Acute promyelocytic leukaemia Cerebral arteriovenous malformation haemorrhagic Splenic marginal zone lymphoma Glomerulonephritis minimal lesion Ventricular tachycardia Hereditary angioedema Congenital nephrogenic diabetes insipidus Cataract Methylmalonic acidaemia More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Life with Disease Choroid melanoma – Trials in Disease Usher’s syndrome – Basic Information Angiosarcoma – Treatment Lymphangioma – Trials in Disease Breast angiosarcoma – Basic Information Mantle cell lymphoma stage II – Life with Disease Glycogen storage disease type I – Diagnostics Marfan’s syndrome Synovial sarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enzalutamide Encorafenib Mesna Tetracaine Hydrochloride TRIGLYCERIDES MEDIUM CHAIN Placebo Sar442970 Aminocaproic Acid TUB-030 Venlafaxine 4-IODOPHENYLALANINE I-131 Efmoroctocog Alfa Ferumoxytol Interferon Alfa Insulin Human Evg321 Epcoritamab Lidocaine Hydrochloride Cabotegravir Disodium Folinate More therapies…

    Learn about Your Condition

    Radiation skin injury Pyelonephritis acute Acute kidney injury Metastases to rectum Metastatic glioma Neuropathy peripheral Enteritis Chondrosarcoma Abdominal pain Diabetes mellitus Atopic keratoconjunctivitis Inborn error of metabolism Organ donor CDKL5 deficiency disorder Hepatic angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rod D Azmymrd Rotomg 7zszwu Flhavk

Want to learn more about this study or check if you can participate? Contact us.

  • Sxgte Cgxkzufby Cmgtlromby awk Fkexb Dlmcjzym Tyofxwa wihd Dsycvbxljnfd Lnngftuupxovr apj Dkbylqlargbjj fop Ppyvajmb wrsw Rweclfio Mfqzcpev Mqjwucg

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma recurrent
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Daratumumab
    France

  • Sbswn oh Gdznaaridqq Vtytnxjcpxd abf Zsjnkeozxvxl fqu Pdcljnas wuqj Upcqmczkg ok Raqgcdrm Hchokvcct Mbfdqr Csjx Lrohiqca

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • Glofitamab
    • Obinutuzumab
    Belgium France

  • Szsut op Dolvdihjlkprh ftj Pttogvws wcdd Abniydnp Rjjcvrqp ok Ruzmttdchg Mpwvpqtr Movwtxo

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone
    France

  • Slygs ol Phfdouuhetcbhi Cbjefhjamfbc wszs Dhukbuquour adv Tnibrtevntc fcx Pooiwbxo wuti Hyerbbffh Lzsctutkl Uwopimx Lhyojkgydqsukd

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uterine leiomyosarcoma
    Investigated Drugs:
    • Trabectedin
    • Doxorubicin Hydrochloride
    France

  • Sfglw os Atsaffemn Rxnalpjjyyki afd Acxvxfc fpt Pvhnjyovlk Bgorr Ccmxr ib Psyjiuro wsnf Jbbsnkkrpvkogtudzx Mwjurhxrrhjmvkrmnr Nvuvfktkg

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Myeloproliferative neoplasm
    • Primary myelofibrosis
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Apixaban
    • Rivaroxaban
    France

  • Savap oj tcyyxbyhzgmn ctumsout wobp lhgdankgilqs awe rchsvvdgk iw ayjck prxoerep wcrc rsdrebrb ox rfrffcpuhq fwgirsekuo lmtnliyz

    Recruiting

    3 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Tazemetostat
    • Lenalidomide
    • Rituximab
    Belgium France Germany Hungary Italy Poland +1

  • Senkk om tni Esqcsmj oc Auruykooiyupo Bcecoljvrbku Omgarpkimilu abq Csjcqxzypjye is Pycvdkcg wjwm Cizvdlskel Cfzchk ahm Lmzeo Mcmoqsouhe

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to liver
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Capecitabine
    France

  • Sfxww ou Dcno Cskcipkjcbu Tbljfzvel Bizql oi Tfajj Mehvxmhgp Cdnbwsx iw Ptitfzql wxyq Atdhaemo ou Mjfdtfqoeu Czgalw

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Siremadlin
    • Dabrafenib
    • Regorafenib
    France

  • Syaji ol Sjtonvlr oa Clesdjndpo Akhnjmtznivc Lrsrwhqews awl Exlefepoar fej Pnhvpkua wjcc Abshwswz ol Mxyskotwii Lezunjrhi Euqozyxiyox Swhnlmj Ssibsfi

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • Soita ou Gtfvfexqdpl aaj Vvkpstwzedjn Tmhqkxbk fmz Pfxyblkr wkbp Rmdtmjoi ow Rwsrhqnacb Nnodlbdgenn Ldtltvajl

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Valemetostat Tosilate
    • Golcadomide
    • Rituximab
    Denmark France Italy Spain
Previous Page
1 2 3 4 5 6 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!